Clinical Tools

• Buprenorphine Induction 
• Childbirth, Breastfeeding and Infant Care: Methadone and Buprenorphine
• Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
• Clinically Relevant Drug Interactions: Buprenorphine or Methadone with Other Frequently Prescribed Drugs
• Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide
• Management of Psychiatric Medications in Patients Receiving Buprenorphine/Naloxone
• Medication for the Treatment of Alcohol Use Disorder: A Brief Guide
• Monitoring of Liver Function Tests and Hepatitis in Patients Receiving Buprenorphine/Naloxone
• Monitoring of Liver Function Tests in Patients Receiving Naltrexone or Extended-Release Naltrexone
• Off-Label Use of Sublingual Buprenorphine and Buprenorphine/Naloxone for Pain
• Physician Billing for Office-Based Treatment of opioid use disorder
• Pregnancy and Buprenorphine Treatment
• Pregnancy: Methadone and Buprenorphine
• Psychosocial Aspects of Treatment in Patients Receiving Buprenorphine/Naloxone
• Transfer from Methadone to Buprenorphine
• Treatment of Acute Pain in Patients Receiving Buprenorphine/Naloxone
• Treatment of Opioid Dependent Adolescents and Young Adults Using Sublingual Buprenorphine

Patient/Family Information

• Sample Buprenorphine Patient Information
• Sample Buprenorphine Information for Family Members

Intake

• Sample Intake Questionnaire
• Sample Initial Patient Contact About Buprenorphine
• Sample Medical History and PE Form

Treatment Agreements

• Sample 1 Treatment Agreement
• Sample 2 Treatment Agreement
• Sample 3 Treatment Agreement
• Sample 4 Treatment Agreement

Induction

• Clinical Opiate Withdrawal Scale
  • COWS Score for Opiate Withdrawal
• Modified OOWS Form

Drug Accountability Forms (if dosing in office)

• Buprenorphine Stock Drug Accountability Record
• Buprenorphine Patient Log

Ongoing Treatment

• Progress Note Example
• Protocol for Follow-up Appointments
• Billing Information

Notification of Intent

• Notification of Intent Waiver Application

TIP

• Tip 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
• TIP 63: Medications for Opioid Use Disorder

• American Academy of Addiction Psychiatry
• American Osteopathic Academy of Addiction Medicine
• American Psychiatric Association
• American Association for the Treatment of opioid use disorder
• American Society for Addiction Medicine
• Addiction Technology Transfer Center
• Buprenorphine Physician Locator
• California Academy of Family Physicians
• Family Resource Center
• Federation of State Medical Boards Model Policy Guideline
• CDC HIV Screening Standard Care Resource Center
• Hepatitis C - FAQs, Statistics, Data, & Guidelines | CDC
• The Mental Health & Substance Use Disorder Parity Task Force – Final Report
• National Institute on Drug Abuse
• National Institute on Mental Health
• SAMHSA Buprenorphine Site
• SAMHSA Opioid Treatment Program Directory